News Releases Year: All News20182017201620152014 Items per page All News2550 Summary ToggleContraVir Pharmaceuticals to Present Three Posters at the 53rd Annual International Liver Congress™ Summary Toggle April 3, 2018 View News Release > Summary ToggleContraVir Pharmaceuticals Announces TXL™ Has Been Granted Orphan Drug Designation for the Treatment of HBV in a Pediatric Population Summary Toggle February 22, 2018 View News Release > Summary ToggleContraVir Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders until March 9, 2018 Summary Toggle February 21, 2018 View News Release > Summary ToggleContraVir Pharmaceuticals Reaches Agreement with the FDA on the NDA Package for TXL™ Leveraging the 505(b)(2) Regulatory Pathway Summary Toggle February 12, 2018 View News Release > Summary ToggleContraVir Pharmaceuticals to Present at BIO CEO & Investor Conference Summary Toggle February 9, 2018 View News Release > Summary ToggleContraVir Pharmaceuticals Completes Renal Impairment Study with TXL™ Summary Toggle February 6, 2018 View News Release > Summary ToggleContraVir Pharmaceuticals Receives Positive Nasdaq Listing Determination Summary Toggle February 5, 2018 View News Release > Summary ToggleContraVir Pharmaceuticals to Present at NobleCon14 Summary Toggle January 23, 2018 View News Release > Summary ToggleContraVir Pharmaceuticals to Present at Biotech Showcase 2018 Summary Toggle January 2, 2018 View News Release > Summary ToggleContraVir Pharmaceuticals Announces John Sullivan-Bolyai, M.D., MPH Steps Down as Chief Medical Officer Summary Toggle December 29, 2017 View News Release > Pagination First page First Previous page Previous … Page 2 Current page 3 Page 4 Page 5 … Next page Next Last page Last
